21
↑0
↓21
—0
Evidence suggests Melatonin maydecreaseCancer.
18 studies (21 claims)
Exact normalized-entity scope. Exact scope. Claims must match the selected normalized intervention and endpoint IDs; signal links are not expanded. Direction describes the stored endpoint phrase and is not a benefit/harm judgement.
19 of 23
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| Melatonin | Decreases - emerging as one of the most effective ... oncostatic molecule | cancer | HumanAnimal | human | — | Photoimmunomodulation and melatonin. |
| melatonin | Decreases - may be of use in the prevention and treatment | cancer | Human | human, animal and cellular studies | Not specified | Mechanisms Underlying Tumor Suppressive Properties of Melatonin.cited 47× |
| melatonin | Decreases - has oncostatic properties | cancer | Human | human, animal and cellular studies | Not specified | Mechanisms Underlying Tumor Suppressive Properties of Melatonin.cited 47× |
| melatonin | Decreases - mitigates pathogenesis | cancer | Human | — | Not specified | Mechanisms Underlying Tumor Suppressive Properties of Melatonin.cited 47× |
| melatonin | Decreases - retard the progression | cancer | Human | — | Not specified | Mechanisms Underlying Tumor Suppressive Properties of Melatonin.cited 47× |
| Melatonin | Decreases - is a promising hormone for preventing cancer | cancer | Human | — | Not specified | Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment.cited 63× |
| melatonin | Decreases - has substantial anticancer properties | cancer | Human | clinical oncology | Not specified | The emergence of melatonin in oncology: Focus on colorectal cancer.cited 48× |
| melatonin | Decreases - shows wide range anticancer activities | cancer | Human | — | Not specified | Melatonin: A new inhibitor agent for cervical cancer treatment.cited 54× |
| Melatonin | Decreases - has anticancer properties | cancer | Molecular | — | Not specified | Melatonin and its ubiquitous anticancer effects. |
| Melatonin | Decreases - anticancer effect | cancer | Molecular | various cancer cells | Not specified | Melatonin and its ubiquitous anticancer effects. |
| melatonin | Decreases - shows a wide range of anticancer activities | cancer | HumanMolecular | — | Not specified | Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma.cited 35× |
| melatonin | Decreases - fortify the anti-cancer effects | cancer | HumanMolecular | osteosarcoma models | Not specified | Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma.cited 35× |
| melatonin | Decreases - having anticancer potentials | cancer | Human | — | Not available | Melatonin and neuroblastoma: a novel therapeutic approach.cited 11× |
| melatonin | Decreases - has anti-cancer characteristics | cancer | Molecular | — | Not specified | Molecular targets for the management of gastrointestinal cancer using melatonin, a natural endogenous body hormone.cited 6× |
| melatonin | No effect - is an appropriate candidate for treatment | cancer | Human | — | — | Molecular and cellular mechanisms of melatonin in breast cancer.cited 9× |
| melatonin | Decreases - anticancer effects | cancer | Human | — | — | Use of Melatonin in Cancer Treatment: Where Are We?cited 47× |
| melatonin | Decreases - exerts its anticancer effect through modification of its receptors | cancer | Human | — | — | Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin. |
| melatonin | Decreases - inhibit | cancer | Molecular | — | Not specified. | Melatonin modulates tumor metabolism and mitigates metastasis.cited 10× |
| melatonin | Decreases - has potential anti-cancer properties | cancer | Human | — | Not specified | Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations.cited 7× |